Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Apogen Biotechnologies Inc.

Headquarters: Seattle, WA, United States of America
Year Founded: 2014
Status: Archived

Historical deals and financings can be found by searching the organization's name in the BCIQ Deals and Financing Modules.

BioCentury | May 31, 2019
Targets & Mechanisms

Targeting cancer evolution offers a way to foil drug resistance

Solutions to cancer drug resistance could come from new understanding about tumor evolution and advances in liquid biopsies.
BioCentury | Aug 31, 2018
Financial News

ApoGen expands series A to $11M

BioCentury | Mar 30, 2017
Emerging Company Profile

Resisting resistance

ApoGen's APOBEC3B inhibitors could keep cancer therapies working longer
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

Analyzing the surge of newco formations involving corporate VCs
BioCentury | Dec 14, 2016
Financial News

ApoGen completes venture financing

BioCentury | Dec 13, 2016
Financial News

ApoGen debuts with $7M

Items per page:
1 - 6 of 6
Username